Supernus Pharmaceuticals
SUPN
#4177
Rank
A$4.00 B
Marketcap
A$69.56
Share price
-1.25%
Change (1 day)
37.83%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : A$0.54 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.54 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$0.58 B9.24%
2024-12-31A$0.53 B2.21%
2023-12-31A$0.52 B-56.42%
2022-12-31A$1.19 B-0.42%
2021-12-31A$1.20 B22%
2020-12-31A$0.98 B22.39%
2019-12-31A$0.80 B8.3%
2018-12-31A$0.74 B270.47%
2017-12-31A$0.20 B23.03%
2016-12-31A$0.16 B18.33%
2015-12-31A$0.13 B17.64%
2014-12-31A$0.11 B35.07%
2013-12-31A$86.92 M148.02%
2012-12-31A$35.04 M-18.86%
2011-12-31A$43.19 M-51.96%
2010-12-31A$89.91 M-6.14%
2009-12-31A$95.79 M-19.43%
2008-12-31A$0.11 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$164.49 B 29,998.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$47.45 B 8,582.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$120.14 B 21,883.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$100.00 B 18,197.72%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
A$1.09 B 100.49%๐Ÿ‡บ๐Ÿ‡ธ USA